Abatacept in Treating Adults With Mild Relapsing Wegener's Granulomatosis
Status:
Completed
Trial end date:
2011-08-01
Target enrollment:
Participant gender:
Summary
Wegener's granulomatosis (WG) is a rare disease that causes inflammation of blood vessels, or
vasculitis. It may involve many different parts of the body, but typically affects the upper
and lower respiratory tract and kidneys. The purpose of this study is to determine the safety
and effectiveness of the medication abatacept in treating adults with mild relapsing WG.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
University of Pennsylvania
Collaborators:
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Office of Rare Diseases (ORD) Rare Diseases Clinical Research Network